A new dengue vaccine (TAK-003) now WHO recommended in endemic areas; what about travellers?
DO Freedman - Journal of Travel Medicine, 2023 - academic.oup.com
Journal of Travel Medicine, 2023•academic.oup.com
Qdenga (Takeda) is now WHO recommended for residents of highly endemic areas.
Travellers from dengue non-endemic countries with previous travel-related dengue (any
serotype) will benefit from TAK-003 vaccination to prevent a secondary dengue infection
during future dengue risk travel. Dengue-naïve travellers have less potential benefit and use
will remain discretionary for now.
Travellers from dengue non-endemic countries with previous travel-related dengue (any
serotype) will benefit from TAK-003 vaccination to prevent a secondary dengue infection
during future dengue risk travel. Dengue-naïve travellers have less potential benefit and use
will remain discretionary for now.
Qdenga (Takeda) is now WHO recommended for residents of highly endemic areas. Travellers from dengue non-endemic countries with previous travel-related dengue (any serotype) will benefit from TAK-003 vaccination to prevent a secondary dengue infection during future dengue risk travel. Dengue-naïve travellers have less potential benefit and use will remain discretionary for now.
Oxford University Press